|
A clear, introductory overview of the issues surrounding gene patenting.
DNA patenting has emerged as a hot topic in science policy and bioethics as private companies and government agencies spend billions of dollars on genetic research and development in a race to identify, sequence, and analyze DNA from human, animal, and plant species. David B. Resnik's Owning the Genome explores the ethical, social, philosophical, theological, and policy issues surrounding DNA patenting and develops a comprehensive approach to the topic. Resnik considers arguments for and against DNA patenting and concludes that only a patent on a whole human genome would be inherently immoral, while the morality of other DNA patents depends on their consequences for science, medicine, agriculture, industry, and society. He also stresses the importance of government regulations and policies in order to minimize the harmful effects of patenting while promoting the beneficial ones.
“Naturally occurring DNA, whether in its natural state, … modified DNA, or even artificial DNA, pose very different questions. This book helps to clarify the moral aspects of these issues.” — Medicine, Health Care & Philosophy: A European Journal
“To Resnik’s credit, he recognizes that the consequences of DNA patents raise empirical questions that will not be definitively resolved for many years.” — New England Journal of Medicine
"For those unfamiliar with the biological material, the legal issues, and the various moral arguments from a diversity of ethical perspectives, this book offers a clear and helpful introduction." — David Edward Shaner, Furman University
David B. Resnik is Professor of Medical Humanities at the Brody School of Medicine at East Carolina University. He is the author of The Ethics of Science: An Introduction and the coauthor (with Holly B. Steinkraus and Pamela J. Langer) of Human Germline Gene Therapy: Scientific, Moral, and Political Issues, and (with Adil E. Shamoo) Responsible Conduct of Research.
|
